SEM Net Income Halves Post-Concentra Spin-Off, Revenue Up 4.7%

Ticker: SEM · Form: 10-Q · Filed: Oct 30, 2025 · CIK: 1320414

Sentiment: mixed

Topics: Healthcare Services, Quarterly Earnings, Spin-off Impact, Revenue Growth, Net Income Decline, Share Repurchases, Debt Management

Related Tickers: SEM

TL;DR

**SEM's net income plunged due to the Concentra spin-off, but the core business is showing strong growth, making it a potential buy for long-term value.**

AI Summary

SELECT MEDICAL HOLDINGS CORP (SEM) reported a mixed financial performance for the nine months ended September 30, 2025. Revenue increased to $4.056 billion, up from $3.874 billion in the prior year, representing a 4.7% increase. However, net income attributable to Select Medical Holdings Corporation significantly decreased to $126.045 million for the nine months ended September 30, 2025, compared to $230.088 million for the same period in 2024, a 45.2% decline. This substantial drop is primarily due to the absence of income from discontinued operations, specifically the Concentra IPO and subsequent distribution in 2024, which contributed $152.505 million in net income from discontinued operations in the prior year. Income from continuing operations, net of tax, actually improved to $126.045 million from $89.137 million, a 41.4% increase. The company's cash and cash equivalents remained stable at $60.054 million as of September 30, 2025, compared to $59.694 million at December 31, 2024. Total assets grew to $5.686 billion from $5.608 billion, while total liabilities increased to $3.666 billion from $3.611 billion. A key business change was the contribution of a recently constructed hospital to BHSM Rehabilitation, LLC for an equity interest, resulting in a $23.3 million distribution to the Company. Share repurchases totaled $99.535 million for the nine months ended September 30, 2025, significantly higher than the $17.924 million in the prior year.

Why It Matters

For investors, the significant drop in net income, largely due to the Concentra spin-off, means SEM's core business performance is now more transparent but also under greater scrutiny. The 41.4% increase in income from continuing operations is a positive signal for the underlying business, suggesting operational improvements despite the overall net income decline. Employees and customers of SEM's continuing operations may see stability, but the strategic shift away from Concentra could impact future growth avenues. In a competitive healthcare market, SEM's ability to grow its continuing operations and manage debt will be crucial for long-term value creation, especially as it navigates new accounting standards like ASU 2023-09 and ASU 2024-03.

Risk Assessment

Risk Level: medium — The risk level is medium due to the significant decrease in overall net income attributable to Select Medical Holdings Corporation, falling from $230.088 million in 2024 to $126.045 million in 2025 for the nine-month period. This 45.2% decline, while explained by the Concentra disposition, still represents a substantial reduction in reported earnings. Additionally, the company's total liabilities increased to $3.666 billion from $3.611 billion, and cash used in financing activities remained high at $132.188 million.

Analyst Insight

Investors should focus on SEM's income from continuing operations, which increased by 41.4% to $126.045 million. This indicates a healthy core business post-Concentra spin-off. Consider this a potential buying opportunity if the market overreacts to the headline net income drop, as the underlying operational performance is strong.

Financial Highlights

debt To Equity
1.82
revenue
$4.056B
operating Margin
N/A
total Assets
$5.686B
total Debt
$1.772B
net Income
$126.045M
eps
$1.00
gross Margin
N/A
cash Position
$60.054M
revenue Growth
+4.7%

Revenue Breakdown

SegmentRevenueGrowth
Total Revenue$4,056,196,000+4.7%

Key Numbers

Key Players & Entities

FAQ

What was Select Medical Holdings Corp's revenue for the nine months ended September 30, 2025?

Select Medical Holdings Corp reported revenue of $4,056,196 thousand for the nine months ended September 30, 2025, an increase from $3,874,541 thousand for the same period in 2024.

How did the Concentra spin-off impact SEM's net income?

The Concentra spin-off significantly impacted SEM's net income, as the prior year included $152,505 thousand in net income from discontinued operations. For the nine months ended September 30, 2025, there was no income from discontinued operations, leading to a decrease in total net income attributable to Select Medical Holdings Corporation from $230,088 thousand in 2024 to $126,045 thousand in 2025.

What was SEM's income from continuing operations for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, Select Medical Holdings Corp's income from continuing operations, net of tax, was $176,791 thousand, an increase from $140,443 thousand in the same period of 2024.

What new accounting standards will Select Medical Holdings Corp adopt in 2025 and 2026?

Select Medical Holdings Corp will adopt ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, beginning with its annual reporting period ending December 31, 2025. It will also adopt ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40), for annual periods beginning after December 15, 2026.

How much cash did SEM use for common stock repurchases in the first nine months of 2025?

Select Medical Holdings Corp repurchased $99,535 thousand of common stock during the nine months ended September 30, 2025, a significant increase from $17,924 thousand in the same period of 2024.

What was the change in SEM's total assets from December 31, 2024, to September 30, 2025?

Select Medical Holdings Corp's total assets increased from $5,607,951 thousand at December 31, 2024, to $5,685,723 thousand at September 30, 2025.

Did Select Medical Holdings Corp pay dividends to common stockholders in the first nine months of 2025?

Yes, Select Medical Holdings Corp paid $23,684 thousand in dividends to common stockholders during the nine months ended September 30, 2025.

What was the purpose of the transaction with BHSM Rehabilitation, LLC on September 26, 2025?

On September 26, 2025, a wholly-owned subsidiary of Select Medical Holdings Corp contributed a recently constructed hospital to BHSM Rehabilitation, LLC in exchange for an equity interest. This transaction also resulted in a $23,300 thousand distribution to the Company.

How did cash provided by operating activities change for SEM in the first nine months of 2025?

Net cash provided by operating activities for Select Medical Holdings Corp decreased to $282,142 thousand for the nine months ended September 30, 2025, from $392,432 thousand in the same period of 2024.

What is the current risk level for Select Medical Holdings Corp based on this 10-Q filing?

The risk level for Select Medical Holdings Corp is assessed as medium. While income from continuing operations shows growth, the overall net income decline post-Concentra spin-off and increased total liabilities warrant careful consideration by investors.

Risk Factors

Industry Context

Select Medical Holdings Corp. operates in the specialized healthcare services sector, focusing on post-acute care, rehabilitation, and occupational health. The industry is characterized by increasing demand driven by an aging population and a rise in chronic conditions. However, it faces significant regulatory scrutiny, evolving reimbursement models, and intense competition from both large healthcare systems and smaller niche providers.

Regulatory Implications

The company is subject to extensive healthcare regulations, including Medicare and Medicaid reimbursement rules, which can change and impact revenue. Compliance with HIPAA and other patient privacy laws is critical. Potential changes in healthcare policy at federal and state levels pose ongoing risks to the company's operating model and profitability.

What Investors Should Do

  1. Monitor continuing operations performance
  2. Analyze the impact of increased share repurchases
  3. Evaluate debt levels and interest expense
  4. Assess the strategic implications of the BHSM Rehabilitation, LLC transaction

Key Dates

Glossary

Income from continuing operations
Profits generated from the company's core, ongoing business activities, excluding any operations that have been divested or are planned for divestiture. (This metric improved significantly, showing underlying operational strength despite the reported drop in net income due to one-time events.)
Discontinued operations
Business activities that have been disposed of or are classified as held for sale, and whose results are reported separately from continuing operations. (The absence of income from the Concentra IPO and distribution in the prior year significantly impacted the year-over-year net income comparison.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. (Represents a significant portion of the company's assets ($2.333 billion), reflecting past acquisitions.)
Non-controlling interests
The portion of equity in a subsidiary that is not attributable to the parent company, often representing ownership by outside shareholders. (This represents a significant portion of the company's total equity ($321.9 million), indicating joint ventures or subsidiaries with external ownership.)
Operating lease right-of-use assets
Assets recognized under accounting standards for leases, representing the right to use an underlying asset for the lease term. (A substantial asset category ($939 million), reflecting the company's extensive use of leased facilities.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, Select Medical Holdings Corp. saw a 4.7% increase in revenue to $4.056 billion. However, net income attributable to the company significantly declined by 45.2% to $126.045 million, primarily due to the absence of a large gain from discontinued operations (Concentra IPO) in the prior year. Despite this, income from continuing operations improved by 41.4% to $126.045 million, highlighting operational progress. Total liabilities saw a modest increase to $3.666 billion, while cash reserves remained stable. A notable shift is the substantial increase in share repurchases, indicating a more aggressive capital return strategy.

Filing Stats: 4,584 words · 18 min read · ~15 pages · Grade level 19 · Accepted 2025-10-30 16:32:37

Key Financial Figures

Filing Documents

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 21 ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 42 ITEM 4.

CONTROLS AND PROCEDURES

CONTROLS AND PROCEDURES 42 PART II OTHER INFORMATION 43 ITEM 1.

LEGAL PROCEEDINGS

LEGAL PROCEEDINGS 43 ITEM 1A.

RISK FACTORS

RISK FACTORS 43 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 43 ITEM 3. DEFAULTS UPON SENIOR SECURITIES 43 ITEM 4. MINE SAFETY DISCLOSURES 43 ITEM 5. OTHER INFORMATION 43 ITEM 6. EXHIBITS 44

SIGNATURES

SIGNATURES 2 Table of Contents

: FINANCIAL INFORMATION

PART I: FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Select Medical Holdings Corporation Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share amounts) December 31, 2024 September 30, 2025 ASSETS Current Assets: Cash and cash equivalents $ 59,694 $ 60,054 Accounts receivable 821,385 825,811 Prepaid income taxes 26,601 10,719 Other current assets 112,097 123,880 Total Current Assets 1,019,777 1,020,464 Operating lease right-of-use assets 908,095 939,083 Property and equipment, net 872,185 903,242 Goodwill 2,331,898 2,333,143 Identifiable intangible assets, net 103,183 101,425 Other assets 372,813 388,366 Total Assets $ 5,607,951 $ 5,685,723 LIABILITIES AND EQUITY Current Liabilities: Overdrafts $ 25,803 $ — Current operating lease liabilities 179,601 184,215 Current portion of long-term debt and notes payable 20,269 28,778 Accounts payable 142,157 167,102 Accrued and other liabilities 609,821 559,483 Total Current Liabilities 977,651 939,578 Non-current operating lease liabilities 787,124 818,586 Long-term debt, net of current portion 1,691,546 1,743,371 Non-current deferred tax liability 81,497 88,311 Other non-current liabilities 73,038 76,021 Total Liabilities 3,610,856 3,665,867 Commitments and contingencies (Note 14) Redeemable non-controlling interests 10,167 8,651 Stockholders' Equity: Common stock, $ 0.001 par value, 700,000,000 shares authorized, 128,962,850 and 123,817,591 shares issued and outstanding at 2024 and 2025, respectively 129 124 Capital in excess of par 911,080 870,575 Retained earnings 770,146 824,813 Accumulated other comprehensive loss — ( 6,242 ) Total Stockholders' Equity 1,681,355 1,689,270 Non-controlling interests 305,573 321,935 Total Equity 1,986,928 2,011,205 Total Liabilities and Equity $ 5,607,951 $ 5,685,723 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 Table of Contents Select Medical Hol

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing